Ironsides Asset Advisors’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-6,286
| Closed | -$541K | – | 69 |
|
|
2024
Q4 | $541K | Sell |
6,286
-472
| -7% | -$40.6K | 0.16% | 40 |
|
|
2024
Q3 | $805K | Buy |
6,758
+3,490
| +107% | +$416K | 0.23% | 34 |
|
|
2024
Q2 | $466K | Hold |
3,268
| – | – | 0.16% | 38 |
|
|
2024
Q1 | $420K | Buy |
3,268
+436
| +15% | +$56K | 0.14% | 47 |
|
|
2023
Q4 | $293K | Sell |
2,832
-686
| -19% | -$71K | 0.13% | 48 |
|
|
2023
Q3 | $320K | Hold |
3,518
| – | – | 0.15% | 50 |
|
|
2023
Q2 | $285K | Hold |
3,518
| – | – | 0.12% | 59 |
|
|
2023
Q1 | $280K | Hold |
3,518
| – | – | 0.13% | 63 |
|
|
2022
Q4 | $238K | Buy |
+3,518
| New | +$238K | 0.11% | 70 |
|
|
2022
Q3 | – | Sell |
-3,818
| Closed | -$213K | – | 98 |
|
|
2022
Q2 | $213K | Hold |
3,818
| – | – | 0.08% | 78 |
|
|
2022
Q1 | $212K | Hold |
3,818
| – | – | 0.06% | 89 |
|
|
2021
Q4 | $214K | Sell |
3,818
-500
| -12% | -$28K | 0.06% | 87 |
|
|
2021
Q3 | $207K | Sell |
4,318
-570
| -12% | -$27.3K | 0.07% | 93 |
|
|
2021
Q2 | $205K | Sell |
4,888
-4,900
| -50% | -$206K | 0.06% | 93 |
|
|
2021
Q1 | $330K | Hold |
9,788
| – | – | 0.1% | 70 |
|
|
2020
Q4 | $342K | Sell |
9,788
-1,350
| -12% | -$47.2K | 0.11% | 65 |
|
|
2020
Q3 | $387K | Sell |
11,138
-4,112
| -27% | -$143K | 0.12% | 61 |
|
|
2020
Q2 | $499K | Hold |
15,250
| – | – | 0.16% | 57 |
|
|
2020
Q1 | $459K | Hold |
15,250
| – | – | 0.28% | 47 |
|
|
2019
Q4 | $441K | Hold |
15,250
| – | – | 0.14% | 63 |
|
|
2019
Q3 | $394K | Buy |
+15,250
| New | +$394K | 0.13% | 64 |
|